- Home
- TRN vs ACAD Comparison
TRN vs ACAD Comparison
Compare TRN & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRN
- ACAD
- Stock Information
- Founded
- TRN 1933
- ACAD 1993
- Country
- TRN United States
- ACAD United States
- Employees
- TRN N/A
- ACAD N/A
- Industry
- TRN Railroads
- ACAD Biotechnology: Pharmaceutical Preparations
- Sector
- TRN Industrials
- ACAD Health Care
- Exchange
- TRN Nasdaq
- ACAD Nasdaq
- Market Cap
- TRN 2.9B
- ACAD 2.9B
- IPO Year
- TRN N/A
- ACAD 2004
- Fundamental
- Price
- TRN $35.83
- ACAD $17.07
- Analyst Decision
- TRN Buy
- ACAD Buy
- Analyst Count
- TRN 2
- ACAD 18
- Target Price
- TRN $34.00
- ACAD $26.53
- AVG Volume (30 Days)
- TRN 491.3K
- ACAD 1.7M
- Earning Date
- TRN 02-20-2025
- ACAD 02-25-2025
- Dividend Yield
- TRN 3.14%
- ACAD N/A
- EPS Growth
- TRN 128.94
- ACAD N/A
- EPS
- TRN 2.05
- ACAD 0.78
- Revenue
- TRN $3,247,700,000.00
- ACAD $929,236,000.00
- Revenue This Year
- TRN $2.77
- ACAD $37.34
- Revenue Next Year
- TRN N/A
- ACAD $7.25
- P/E Ratio
- TRN $15.93
- ACAD $21.99
- Revenue Growth
- TRN 16.97
- ACAD 47.06
- 52 Week Low
- TRN $23.40
- ACAD $14.15
- 52 Week High
- TRN $39.00
- ACAD $31.93
- Technical
- Relative Strength Index (RSI)
- TRN 44.55
- ACAD 51.57
- Support Level
- TRN $34.90
- ACAD $16.27
- Resistance Level
- TRN $36.59
- ACAD $17.86
- Average True Range (ATR)
- TRN 1.11
- ACAD 0.77
- MACD
- TRN -0.31
- ACAD -0.10
- Stochastic Oscillator
- TRN 29.56
- ACAD 28.78
About TRN Trinity Industries Inc.
Trinity Industries Inc. sells and leases railroad products and railcar maintenance services in North America. The company operates under the name TrinityRail in three main segments: railcar leasing and management services, which owns railcars and provides fleet management and administration services; rail products, which builds, sells, and modifies freight and tank railcars and their components; and all other, which sells highway products such as guardrail and other highway barriers. Customers include railroads, leasing companies, and shipping companies in the industries of agriculture, construction, consumer products, energy, and chemicals.
About ACAD ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.